Business Description
Ainos Inc
NAICS : 423450
SIC : 5047
ISIN : US02301P2056
Description
Ainos Inc is engaged in developing biologics for the treatment of human and animal diseases. The company mainly focuses on the research of the treatment of human disease indications, particularly influenza, hepatitis C, thrombocytopenia, and other indications using natural human interferon-alpha that is administered in a proprietary low-dose oral form. Its product pipeline includes VELDONA Pet cytoprotein supplements for pets, VELDONA human therapeutics for clinical use, and telehealth-friendly POCTs powered by the AI Nose technology platform.
Financial Strength
3/10
| Name | Current | Vs Industry | Vs History | |||
|---|---|---|---|---|---|---|
| Cash-To-Debt | 0.42 | |||||
| Equity-to-Asset | 0.57 | |||||
| Debt-to-Equity | 0.68 | |||||
| Debt-to-EBITDA | -1.13 | |||||
| Piotroski F-Score | 1/9 | |||||
| Altman Z-Score | -3.4 | |||||
| Beneish M-Score | -15.61 | |||||
| WACC vs ROIC | ||||||
Growth Rank
3/10
| Name | Current | Vs Industry | Vs History | |||
|---|---|---|---|---|---|---|
| 3-Year Revenue Growth Rate | -1.1 | |||||
| 3-Year EBITDA Growth Rate | 6.7 | |||||
| 3-Year EPS without NRI Growth Rate | -2.8 | |||||
| 3-Year FCF Growth Rate | -7.7 |
Momentum Rank
8/10
| Name | Current | Vs Industry | Vs History | |||
|---|---|---|---|---|---|---|
| 5-Day RSI | 21.81 | |||||
| 9-Day RSI | 34.79 | |||||
| 14-Day RSI | 41.81 | |||||
| 3-1 Month Momentum % | 45.05 | |||||
| 6-1 Month Momentum % | 6.25 | |||||
| 12-1 Month Momentum % | -33.33 |
Liquidity Ratio
| Name | Current | Vs Industry | Vs History | |||
|---|---|---|---|---|---|---|
| Current Ratio | 1.37 | |||||
| Quick Ratio | 1.33 | |||||
| Cash Ratio | 1.25 | |||||
| Days Inventory | 349.92 | |||||
| Days Sales Outstanding | 57.87 |
Dividend & Buy Back
| Name | Current | Vs Industry | Vs History | |||
|---|---|---|---|---|---|---|
| 3-Year Average Share Buyback Ratio | -102.8 | |||||
| Shareholder Yield % | -82.41 |
Profitability Rank
3/10
| Name | Current | Vs Industry | Vs History | |||
|---|---|---|---|---|---|---|
| Gross Margin % | -348.78 | |||||
| Operating Margin % | -36363.42 | |||||
| Net Margin % | -39351.22 | |||||
| FCF Margin % | -15419.51 | |||||
| ROE % | -71.05 | |||||
| ROA % | -49.68 | |||||
| ROIC % | -48.62 | |||||
| 3-Year ROIIC % | -41.45 | |||||
| ROC (Joel Greenblatt) % | -1886.91 | |||||
| ROCE % | -53.73 |
GF Value Rank
| Name | Current | Vs Industry | Vs History | |||
|---|---|---|---|---|---|---|
| PS Ratio | 58.59 | |||||
| PB Ratio | 0.4 | |||||
| EV-to-EBIT | -0.93 | |||||
| EV-to-EBITDA | -1.34 | |||||
| EV-to-Revenue | 354.66 | |||||
| EV-to-FCF | -2.3 | |||||
| Price-to-GF-Value | 2.64 | |||||
| Earnings Yield (Greenblatt) % | -107.53 | |||||
| FCF Yield % | -85.11 |
Operating Revenue by Business Segment
Operating Revenue by Geographic Region
Historical Operating Revenue by Business Segment
Historical Operating Revenue by Geographic Region
Guru Trades
See DetailsInsider Trades
See DetailsGurus Latest Trades with NAS:AIMD
You need a Premium membership or above to view this section.
Take a 7-Day Free Trial
No Available Data
Peter Lynch Chart
Performance
Dividend
Log
Bar
Annualized Return % Â
Total Annual Return % Â
Ainos Inc Executives
DetailsAnalyst Estimate
Key Statistics
| Name | Value | ||
|---|---|---|---|
| Revenue (TTM) (Mil $) | 0.041 | ||
| EPS (TTM) ($) | -2.8 | ||
| Beta | 2.32 | ||
| 3-Year Sharpe Ratio | -0.32 | ||
| 3-Year Sortino Ratio | -0.54 | ||
| Volatility % | 68.53 | ||
| 14-Day RSI | 41.81 | ||
| 14-Day ATR ($) | 0.073382 | ||
| 20-Day SMA ($) | 0.634823 | ||
| 12-1 Month Momentum % | -33.33 | ||
| 52-Week Range ($) | 0.4 - 3.1 | ||
| Shares Outstanding (Mil) | 14.09 |
Piotroski F-Score Details
Year:
| Component | Result | ||
|---|---|---|---|
| Piotroski F-Score | 1 | ||
| Positive ROA | |||
| Positive CFROA | |||
| Higher ROA yoy | |||
| CFROA > ROA | |||
| Lower Leverage yoy | |||
| Higher Current Ratio yoy | |||
| Less Shares Outstanding yoy | |||
| Higher Gross Margin yoy | |||
| Higher Asset Turnover yoy |
Ainos Inc Filings
| Filing Date | Document Date | Form | ||
|---|---|---|---|---|
| No Filing Data | ||||
Ainos Inc Stock Events
| Event | Date | Price ($) | ||
|---|---|---|---|---|
| No Event Data | ||||
Ainos Inc Frequently Asked Questions
What is Ainos Inc(AIMD)'s stock price today?
The current price of AIMD is $0.53. The 52 week high of AIMD is $3.10 and 52 week low is $0.40.
When is next earnings date of Ainos Inc(AIMD)?
The next earnings date of Ainos Inc(AIMD) is 2025-03-07 Est..
Does Ainos Inc(AIMD) pay dividends? If so, how much?
Ainos Inc(AIMD) does not pay dividend.
Press Release
| Subject | Date | |||
|---|---|---|---|---|
| No Press Release | ||||
Survey
We'd love to learn more about your experiences on GuruFocus.com and how we can improve!
Take Survey
Follow Us
Disclaimers